Novartis paid Takeda $3.4 billion for its FDA-approved dry eye drug Xiidra during the Japanese pharma’s merger with Shire in 2019, outlining the sales potential in this market niche. But with ...

Shire has launched its dry eye treatment Xiidra (lifitegrast) in the US, a drug the company hopes will achieve blockbuster status. The Dublin-based, London-listed company said Xiidra is available ...

A new eye drop called lifitegrast (Xiidra) also curbs inflammation and can improve signs and symptoms of dry eye. You use these drops twice a day, too. You may get relief in as little as two weeks.

Pre-tax losses at the main Irish unit of eye care product firm Bausch + Lomb increased by 4.5% to $959.7m (€925m) in 2023.

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised ads and content, ad and content measurement, audience ...